Patents
Patents for C07J 5 - Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, and substituted in position 21 by only one singly bound oxygen atom (1,937)
06/1999
06/30/1999CN1220996A Intermediate for preparation of 16 Beta-methyl steroid
06/17/1999WO1998020151A9 A method for the preparation of steroid compounds
06/10/1999WO1999028336A1 METHOD OF PREPARING 16α,17α-DIALKYLATED STEROIDS
06/10/1999CA2299396A1 Method of preparing 16.alpha.,17.alpha.-dialkylated steroids
05/1999
05/27/1999WO1999025359A1 New composition of matter
05/26/1999EP0804459A4 Therapeutic compound - fatty acid conjugates
05/19/1999EP0916658A1 Assays utilizing improved chemiluminescent esters, thioesters and amides
05/14/1999WO1999001467A3 Therapeutically active compounds with low systemic activity due to reduce half life
05/06/1999EP0589034B1 Method for making 3-alpha-hydroxy,3-beta-substituted-pregnanes
04/1999
04/07/1999EP0570454B1 Novel steroids
04/06/1999US5892069 Estrogenic compounds as anti-mitotic agents
04/06/1999US5892028 17, 20-epoxy steroids
03/1999
03/31/1999EP0904266A1 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
03/17/1999CN1042539C 11,21-bisphenyl-19-norpregnane derivatives
03/10/1999EP0900234A1 21-substituted progesterone derivatives as new antiprogestational agents
03/03/1999EP0898579A1 Pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
03/03/1999CN1209811A New 19-nor-pregene derivatives
02/1999
02/24/1999CN1209138A Process for prepn. of 9,11 beta epoxide steroids
01/1999
01/28/1999WO1999003503A1 The use of angiostatic steroids in photodynamic therapy
01/28/1999CA2296558A1 The use of angiostatic steroids in photodynamic therapy of ocular neovascularization
01/14/1999WO1999001467A2 Therapeutically active compounds with low systemic activity due to reduce half life
12/1998
12/30/1998EP0886645A1 New 19-nor-pregnene derivatives
12/29/1998US5854235 17-spiromethylene steroids
12/09/1998CN1201038A Sulfurization for oestrogen mixture
12/09/1998CN1041054C Method for preparing medicine composition containing steroid 5-alpha-reductase inhibitors
12/01/1998US5843933 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
12/01/1998US5843931 6,7-modified 11β-aryl-4-oestrenes
11/1998
11/26/1998WO1998036733A3 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
11/12/1998WO1998050042A1 Pregnan-3-ol-20-ones
11/12/1998CA2289006A1 Pregnan-3-ol-20-ones
11/11/1998CN1040647C Process for preparing 16 alpha-methylated steroids
11/04/1998EP0875515A2 "Sulfatation of estrogen mixtures"
10/1998
10/28/1998EP0873352A1 PROCESS FOR PREPARATION OF 9,11$g(b)-EPOXIDE STEROIDS
10/27/1998US5827841 Method for enhancement of production of lymphokines and applications thereof
10/20/1998US5824670 17-deoxycorticosteroid-21- O!carboxylic esters, processes for their preparation and pharmaceuticals containing these compounds
10/20/1998US5824669 Treating asthma
09/1998
09/16/1998EP0650496B1 Anti-inflammatory compounds for ophthalmic use
09/16/1998EP0624162B1 Novel steroid intermediates and processes for their preparation
09/02/1998CN1039646C Preparation process for an 11-keto steroid derivatives
09/01/1998US5801165 Antiinflammatory, immunosuppressive and antialleric 16, 17-alkylidioxy-steroids
08/1998
08/27/1998WO1998036733A2 Topical pharmaceutical composition comprising a cholinergic agent or a calcium channel blocker
08/26/1998CN1191542A Nor-pregnanes for inducing hypothalamic effects
08/20/1998WO1998035701A1 Drug targeting
08/20/1998CA2280874A1 Bioreductive conjugate for targeting a therapeutic agent
08/18/1998US5795982 Intermediates for 16β-methyl steroids
08/18/1998US5795870 Steroid ring with amine group side chains
08/12/1998CN1190404A Neuroactive steroids of androstane and pregnane series
08/11/1998US5792859 For preparation of corticoids, antiinflammatory agents
08/11/1998US5792757 19-nor-pregnane steroids as neurochemical initiators of change in human hypothalamic function
07/1998
07/30/1998WO1998032718A1 New fatty acid derivatives
07/29/1998CN1039329C Process for preparing steroid esters compound
07/23/1998WO1998031352A1 New formulation for inhalation having a poured bulk density of 0.28 to 0.38 g/ml, a process for preparing the formulation and the use thereof
07/07/1998US5776922 Antiallergens, antiinflammatory agents, cataract and antiischemic organ disease
06/1998
06/23/1998US5770748 20-alkanoyloxy-pregnadiene-3-one-21-nitrile intermediates foroxoetiocholenic acid
06/23/1998US5770592 Vision defects
06/16/1998CA2051670C Conversion of delta 16-steroid to a delta 17 (20)-20-silyl ether
06/02/1998CA2019013C Process to improve the therapeutic efficacy of fat-soluble corticosteroids and composition for the application of this process
05/1998
05/20/1998CN1182092A New 17, 20-epoxide derivatives of pregnane
05/14/1998WO1998020151A1 A method for the preparation of steroid compounds
05/12/1998US5750745 Process for preparing delta 9, 11 and 21-chlorocorticosteroids
04/1998
04/29/1998EP0837874A2 Neuroactive steroids of the androstane and pregnane series
04/08/1998CN1178535A Therapeutic compound-fatty acid conjugates
04/01/1998EP0572451B1 Novel steroid esters
03/1998
03/25/1998EP0830369A1 Novel nor-pregnanes for inducing hypothalamic effects
03/24/1998US5731447 Process for preparing 16α-methyl-steroids
03/17/1998US5728689 11β-aryl-4-estrenes, process for their production as well as their use as pharmaceutical agents
03/03/1998US5723638 Process for 20-oxo-17α,21-diol steroids
02/1998
02/18/1998EP0823897A1 Nicotinic acid esters and pharmaceutical compositions containing them
02/18/1998EP0823895A1 Fatty acid esters as bioactive compounds
02/18/1998EP0823889A1 1,3-propane diol derivatives as bioactive compounds
02/11/1998CN1173181A Pregnanes and cholanes as neurochemical initiators of change in hypothalamic function
01/1998
01/28/1998EP0489779B1 Ophthalmic composition
01/27/1998US5712264 17-spiromethylene steroids
01/21/1998CN1171114A Androstane and preg nane series for allosteric modulation of gamma-amino-butyric acid receptor
12/1997
12/17/1997CN1036719C Preparation process for 20-oxo-17 alpha, 21-dihydroxylated derivs. of pregnane
12/17/1997CN1036718C Method for preparing 19-demethyl steroid compound having thiocarbon chain at 11-beta position
12/16/1997US5698545 Angiostatic steroids and methods and compositions for controlling ocular hypertension
11/1997
11/26/1997EP0808325A1 Androstane and pregnane series for allosteric modulation of gaba receptor
11/26/1997CN1036521C Process for preparing ester of organic acid with alcohol derivatives of 19-norsteroids and their salts
11/12/1997EP0659080A4 Method and composition for the treatment of hair loss.
11/06/1997WO1997041145A1 21-substituted progesterone derivatives as new antiprogestational agents
11/06/1997CA2668824A1 21-substituted progesterone derivatives as new antiprogestational agents
11/05/1997EP0804459A1 Therapeutic compound - fatty acid conjugates
11/05/1997CN1036342C Process for preparing 9,11-dehydro steroids and 9-alpha-hydroxy-16,17-dehydro steroids
10/1997
10/28/1997US5681964 Permeable, non-irritating prodrugs of nonsteroidal and steroidal agents
10/23/1997WO1997039018A1 New pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
10/23/1997CA2251642A1 New pregnane derivatives with no alpha-17 substitutent, their medicinal use, manufacturing method and its intermediaries and related compounds
10/21/1997US5679668 Method of controlling fertility in males with 20-substitute of steroids
10/21/1997US5679666 Administering topically, systemically or intraocularly to a host steroids selected from pregnadien derivatives, hydroxyprogesterone and tetrahydrocortexolone
10/07/1997US5674861 Fluorinated steroids
10/01/1997CN1160719A Introduction method of 9-11 double bond into steroid hormone compound
09/1997
09/25/1997WO1997034871A1 Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
09/24/1997CN1035948C Process for preparation of pregna-1,4-diene-3,20-dione derivs.
09/24/1997CN1035947C Preparation process for hydrocortisone and intermediates
09/23/1997US5670676 Chlorination in the presence of a strong anhydrous acid
09/10/1997CN1158726A Process for making pharmaceutical formulation containing novel steroid esters
08/1997
08/27/1997EP0567469B1 14beta-H-, 14- AND 15-EN-11beta-ARYL-4-ESTRENES
08/26/1997US5661143 Inhibits (de)polymerization of tubulin to form cellular microtubes; anticarcinogenic,-tumor, inflammatory and wound healing agents; immunology; angiogenesis inhibitors
08/05/1997US5654293 Topical oil-in-water emulsion compositions containing ketoconazole and an acetonide glucocorticosteroid
07/1997
07/31/1997WO1997027210A1 New 19-nor-pregnene derivatives
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20